Alzheimer's disease (AD) is a complex neurodegenerative disease with various deleterious perturbations in regulatory pathways of various brain regions. Thus, it would be critical to understanding the role of different regions of the brain in initiation and progression of AD, However, owing to complex and multifactorial nature of this disease, the molecular mechanism of AD has yet to be fully elucidated. To confront with this challenge, we launched a meta-analytical study of current transcriptomics data in four different regions of the brain in AD (Entorhinal, Hippocampus, Temporal and Frontal) with systems analysis of identifying involved signaling and metabolic pathways. We found different regulatory patterns in Entorhinal and Hippocampus regions to be associated with progression of AD. We also identified shared versus unique biological pathways and critical proteins among different brain regions. ACACB, GAPDH, ACLY, and EGFR were the most important proteins in Entorhinal, Frontal, Hippocampus and Temporal regions, respectively. Moreover, eight proteins including CDK5, ATP5G1, DNM1, GNG3, AP2M1, ALDOA, GPI, and TPI1 were differentially expressed in all four brain regions, among which, CDK5 and ATP5G1 were enriched in KEGG Alzheimer's disease pathway as well.
Early AD diagnosis in combination with new classes of neuroprotective or disease-modifying drug treatments may delay or prevent the neurodegenerative effects of AD [3] . Attempts at symptomatic relief are only modestly effective ,and still, there isn't a proper report on some curative treatment [4] , although many researchers focused on different aspects of this disease and tried to shed light on its diagnosis [5] .
However, due to long preclinical and prodromal phases and the symptom-free episodes, the initiating factors of AD are still unclear ,and it seems likely that a sort of brain damage starts a decade or more before problems become evident [5] . So, AD continuously is a major target of both clinical and basic types of research.
It is assumed that many factors and their interactions contribute to the pathogenesis of AD. Thus, a holistic research regarding the mechanism of AD is of great importance [6, 7] . AD is a multi-factor disease that has two forms, early onset familial Alzheimer disease (EFAD) that inherited in an autosomal dominant manner [8] and Late-onset Alzheimer's disease (LOAD) or non-familial [9] that appears as a much more complex or multifactorial disease [10] . The point is that regardless the Alzheimer's form there isn't any significant diagnostic report before the appearance of Alzheimer's hallmarks.
The AD's hallmarks associated with microscopic features including appearance of Neurofibrillary represent the situation that neurofibrillary tangles of the transentorhinal region of the brain are involved. At the stages of III and IV the limbic region (such as the Hippocampus) is also involved and finally, at the stages of V and VI, an extensive neocortical involvement is detectable [18] . Altogether, abnormal deposits of proteins form amyloid plaques and tau tangles throughout the brain, leading to deficits in neurons plasticity and apoptosis and the resultant brain shrinkage over the time. With damage reaching the Hippocampus, (stage III and IV), substantial memory loss would be expected has been shrunken significantly [9] .
Classical reductionist research methods are incapable of coping the complex nature of multifactorial diseases such as AD in which, both individual's genetic background and environmental conditions are involved. Thus a systems level methodology with an integrative and holistic approach would be highly demanding in this area to identify critical interactions between hereditary and environmental factors. .Also, models were designed by these approaches to understanding initiation. To reach this goal, A large number of microarray datasets belonging to different brain regions of AD patients are available [19] [20] [21] in public databases. Herein, we used these data to shed light on the role of important pathways in brain regions associated with AD. In this regard we meta-analyzed qualified microarray data belonging to four brain regions of patients with AD including Entorhinal, Frontal, Hippocampus, and Temporal) and followed a network-based approach to identify brain-region-specific pathways/genes. Furthermore, we supplemented our results with current knowledge-and data-driven networks to decipher possible crosstalk between Hippocampus-Frontal in the brain regions of Alzheimer's patients. In general, 110 data-series belonging to 8 regions of brain deposited in GEO and Array Express databases based on "Alzheimer" and "Homo sapiens" keywords. To decrease heterogeneity as well as increasing the consistency between expressing data-series, only Human Genome U133 Plus 2.0 Array (HG-U133_Plus_2) or Human Genome U133A ver2.0 (U133A) platforms from Affymetrix Company were selected. Finally, the data-series of four regions including Entorhinal, Frontal, Hippocampus and Temporal out of eight brain regions were selected after quality assessment. A summary of the above procedures and the applied methods is presented in figure 1. (Table S1 ). Benjamini-Hochberg Adjustment used for adjustment of p-values [27, 28] . Also, fold change of ≥ I2I and false discovery rate ("FDR) ≤ 10−3" was used for identification of differential gene expression. In order to compare four brain regions, unique DEGs of each region (DEGs that only express in one region) was selected, sorted based on their fold change, and top 10% of DEGs were enriched for GO Biological Process (Table S2 ). [14, 31] . All significant pathways (p-value < 0.05) were identified for each meta-analyzed region of the brain involved in AD (Table 2 ). The enriched pathways were classified as "identical" assuming shared pathways among all four studied brain regions and "non-Identical" pathways, to address to other pathways which may be identical between two or three of them. Also, enriched pathways were categorized in three classes including signaling, metabolic, and disease (Table 2 ). 4  N  e  t  w  o  r  k  r  e  c  o  n  s  t  r  u  c  t  i  o  n A network is a graph of nodes (genes/proteins) and edges (interactions) [32] . In this study, we reconstructed two networks based on knowledge-and data-driven approaches. First, a protein-protein interaction network (PPI) was constructed based on prior knowledge of signaling and metabolic pathways in different pathway databases (section 5-1). Then, a reverse-engineering approach was applied as a data-driven method (section 5-2). Figure 6 ) representing the multi-regional network in the brain of Alzheimer's patients. BPNA network was decomposed into five sub-networks to identify region-specific networks including BPNA SEED (proteins of identical pathways which is described in section-4), BPNA FRO (proteins of non-identical pathways of the Frontal region), BPNA ENT, BPNA HIPP and BPNA TEM as is illustrated in figure 8 (Table S3 ). The number of clusters was determined by "fviz dend" algorithm in this package ( Figure S1 ). Results of dendrogram were shown in Table S6 and the complete results supplied in supplementary files ( Figure S1 ).
-
Clustered genes were enriched based on their class by Enrichr database (refer to section 3). For a better understanding of relationships between regions, clustering of brain regions was performed on data ( Figure   5 -a). Finally, expression of all probesets was applied to draw clustering dendrogram between regions ( Figure 3 ).
We used two methods of cross-validation including literature mining and reconstruction of gene regulatory network of ARACNe. First, differential and critically identified proteins in BPNA were used for literature mining (Table S7 ). Then, ARACNe network was constructed for each region of the brain.
Afterward, results were compared between different methods. Nodes with a degree above average were selected as hubs. Also, Hubs were extracted and compared to intra-and inter-region correlation results.
3
-R e s u l t s
Despite the clinical progression and advanced studies in the field of Alzheimer`s disease (AD), its diagnosis and curation remain unclear. Many separated meta-analytical studies suggested the possibility of sharing a common feature among different AD brain regions [42] [43] [44] . Herein, we have tried horizontal and vertical data integration approach to unify heterogeneous microarray studies for several regions of the brain in AD patients and investigate their possible signaling and regulatory relationships. Also, a network approach was followed to investigate key effective genes in the initiation and progression of AD through different brain regions. Among 110 transcriptomics brain studies in Alzheimer's patients with about 2000 samples in overall, four brain regions including Entorhinal, Frontal, Hippocampus, and Temporal were selected for meta-analysis following quality assessment and just in Temporal region one sample was excluded ( Figure   2 and Table 2 ). Afterward, DEGs in each brain region were identified (FDR≤10 −3 , fold change >I2I)".
Hippocampus region with 1438 genes presented the highest number of DEGs, and the Entorhinal region with 486 genes showed the lowest number of DEGs. Frontal and Temporal regions with 1131 and 998 genes ranked between Hippocampus and Entorhinal, respectively. Detailed results for meta-analysis of each brain region is provided in the supplementary file of Table S1 . In the first step of correlation analysis, all genes in all samples of brain regions were clustered ( Figure 3 ). Generally speaking, clustering of brain samples showed that Entorhinal has a negative correlation with other brain regions, while there are some positive and negative correlations between the samples from Frontal, Temporal and Hippocampus regions. To identify effective genes, pairwise correlation analysis was performed using selected genes in all samples (Figure 4 Results showed that Entorhinal region has less number of hubs than other regions in each comparison.
The samples from different brain regions were classified based on; a-all expression data and b-DEGs. All four brain regions are clearly clustered when all genes are used for clustering ( Figure. 5a ).
However, clustering of brain regions based selected DEGs showed different results ( Figure 5b ).
Interestingly, almost all Entorhinal samples are clustered in one distinct group, and other samples of three other regions are co-clustered. Therefore, gene expression profile in Entorhinal shows a different pattern in comparison with other brain regions.
Additionally, DEGs were clustered in two distinct groups of up-regulated and down-regulated genes ( Figure 6 and Table S6 ). Each cluster was used for gene enrichment analysis (Table S6) .
Neurodegenerative disease pathways (including AD, Huntington, and Parkinson) and oxidative phosphorylation pathways were enriched for the up-regulated cluster ,but cell cycle and proteasome were enriched for the down-regulated cluster (Adjusted p-value <0.05 ). Alzheimer's disease pathway was clustered in one module. Eight proteins were dysfunctional in all four regions including DNM1, GNG3, AP2M1, CDK5, ATP5G1, ALDOA, GPI, and TPI1. NDUFB1, NDUFA2, NDUFB4 and NDUFB11 and showed different behavior compared to other hub proteins in their closeness index. Interestingly, proteins of KEGG Alzheimer's disease pathway tend to have a high degree.
To determine the effective pathways in each brain region and related to Alzheimer progression, BPNA network was decomposed into two sub-network groups based on eight identical pathways and nonidentical pathways (enrichment results) of the brain region. Proteins of eight identical pathways were used to induce a subgraph called BPNA seed . The sub-network consisted of 196 DEGs from different brain regions (figure 7). Afterward, proteins from non-identical enriched pathways were used to induce four brain-region-specific sub-graphs including BPNA FRO (208 proteins), BPNA ENT (75 proteins), BPNA HIPP (407 proteins) and BPNA TEM (335 proteins).
The frequency of protein numbers in identical pathways for different brain regions in figure 8 indicate that the Hippocampus region includes the most proteins in each identical pathway, most of the non-identical pathways belonged to Hippocampus and Entorhinal includes the less number of pathways (Table 2) .
All decomposed networks constructed from BPNA are represented in figure 9 (proteins of all selected pathways). In BPNA SEED network (Figure 9 -a), disease pathways (24%), signaling pathways (16%) and metabolic pathways (12%) have the most number of specific proteins. Interestingly, 21 of 25 high degree proteins, belonged to KEGG Alzheimer's disease pathway. UQCRC1, NDUFB1, NDUFB4, NDUFB11, NDUFA2, NDUFA5 and GAPDH were hub proteins of this brain region in AD patients.
Interestingly, in this network GAPDH was special protein belonging to all three mentioned classes of pathways, also is a KEGG Alzheimer's disease pathway protein and were in top ten lists of high degree proteins, first in high B.C and C.C and 9 th in low topological coefficient. Figure 9 b-e is representing specific sub-graphs. In Entorhinal region (BPNA ENT ), ACACB protein (expressed in both metabolic and signaling pathways) has the highest degree ( Figure 9 -c). In this subnetwork, NDUFB4, NDUFS7, NDUFB7, and ATP5D, were proteins that have a degree above average (Hub) but very low B.C and C.C.ADCY9 (the enzyme that catalyzes the formation of the cyclic AMP from ATP) was the only protein that contributed in all three classes of pathways.
In BPNA FRO GAPDH (a protein of KEGG Alzheimer's disease pathway) had the highest degree, (Figure 9 -b). BPNA TEM showed different characterization. This network has 20 proteins (6% of all nodes of this network) that contributed in all signaling, metabolic and disease pathways and interestingly almost all of them modularized in oxidative phosphorylation pathway (based on KEGG Mapper analysis). These proteins include UQCRFS1, UQCR10, UQCRQ, UQCRC2, COX5A, UQCRC1, COX8A, ATP6V1H, ATP6V1B2, ATP6V0A1, ATP6V0C, ATP6V1E1, ATP6V0D1, ATP6V0E2, ATP6V0B, ATP6V0E1, ATP6V1G2, ATP6AP1, ATP6V1D, and PLCG1. First seven proteins also contribute to KEGG Alzheimer's disease pathway. EGFR included the highest degree in BPNA TEM (Figure 9 -e).
Finally, BPNA HIPP contained 391 nodes and was the largest sub-network. ACLY had the highest degree in BPNA HIPP network (Figure 9-d) .
Based on the MetaQC analysis, GSE5281 data series were selected for ARACNe analysis in all four brain regions. 
All differentially expressed genes during this meta-analysis are available in Table S7 . We have reported 100 Up and 486 down-regulated genes in Alzheimer disease in all brain regions completely that more than 75% of our reported in each group were validated. Summary of Cross-validation statistic is shown in Table 4 .
Relating global expression pattern of multiple genes in AD to the different regions of the brain and deciphering AD progression in these regions is a serious part of the research because AD is one of the most common neurodegenerative disorders. Some related studies on brain regions of Alzheimer patients were accomplished previously. Ray et al. by analyzing microarray data of brain regions showed that middle temporal gyrus is a good choice for detecting early AD pathogenesis [43] . Wang et al.
extract sample from 19 cortical regions of 125 individuals and after defining DEGs and ranking brain region based on relevance to AD, construct co-expression networks for each brain region.
Their analyses identified temporal lobe gyri as earliest gene expression abnormalities region [45] .
Our meta-analysis results showed that Entorhinal region has the minimum number of DEGs with respect to other regions. Also in some analysis results, Entorhinal showed consistently unique behavior compared to other regions: A) In correlation analysis: displayed negative correlation with other brain regions ( Figure 3) (Table 3) . Interestingly, there are several integrative observations indicating the beginning of AD from entorhinal [46] [47] [48] [49] . Mapping of histology and imaging-based data (MRI and PET) in different studies have revealed the critical and initial function of the entorhinal region in AD pathogenesis. We have also observed different expression pattern for entorhinal (more hubs and inverse pairwise correlation) in comparison to other studied regions.
The results of meta-analysis also indicated the highest number of DEGs in Hippocampus. Pairwise and correlation gene expression analysis between regions of brain w showed that Entorhinal region has different manner with respect to other regions and control another part of the brain (see above). Reviewing clinical case studies on the AD patient whose disease progression has been monitored using brain imaging techniques demonstrated that brain atrophy initiated from the limbic lobe ( A clear crosstalk was observed between various brain regions in AD patients so related pathwayssome of which are shared among regions-were functioning simultaneously. Also, two distinct classes of pathways were over-(neurodegenerative diseases and related pathways) and under-(cell cycle and proteasome) represented. Because of limitation in data sources, results of this research were not ideal, and by sampling from all brain regions of AD patients, can perform completely. Altogether, application meta-analysis in connects to complete sampling resulted in identifying beginning and progression factors of AD.
We observed that GAPDH had the highest node degree protein in Hippocampus and frontal regions, in addition, this protein was connected to proteins in all brain regions. GAPDH isoforms have been found in the brains of AD patients 
-
In this study, we investigated the pattern of damage flow through multiple regions of the brain in AD using meta-analysis techniques. Moreover, the result of this study is consistent with former findings on protein expression pattern in the network of neurodegenerative diseases with special focus on AD. By linking the sequence of disease progression through multiple brain regions with DEGs observed in each brain area, the key role of underlying genes associated with initiation and progression of the disease.
Besides, we showed meta-analysis techniques to be reliable in studying effective factors in disease progressing by creating an overall scope of operating disease factors. Altogether, we have identified that entorhinal shows different expression profiling than other three studies regions.
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-R e f e r e n c e s : L e g e n d s : Figure 1 -The Summary of the overall procedure and applied methods in this article. After selection and qualification proper Alzheimer datasets (step 1 and 2), MetaDE was performed on selected datasets (step 3) and DEGs were used for knowledge-driven analysis. First, pathways enrichment using KEGG was accomplished (step 4), then by combining all proteins of selected pathways (P-value < 0.05), BPNA network was constructed (step 5). By decomposing BPNA, five networks were reconstructed (step6). On the other side, on the best dataset in each region, GRN construction (ARACNe analysis) was performed (step 7), and pairwise correlation test was performed on all selected proteins from step 3 between regions (step 8). Results from step 6 compared with step 7 (step 9). Also, expression Condition of all proteins of BPNA (Up-regulated, Down-regulated or others) were validated in literature mining and compare with results of the meta-analysis were compared (step10). For more details, see materials and methods. Figure 9-Decomposition of BPNA network into several subnetworks. All common genes between four different brains regions are colored in gray. Unique genes are colored based on the category of biological pathways (according to Table 2 ). The differences in gene expression based on metaomics analysis have been illustrated with different shapes ( , and for each of upregulated, downregulated and notdifferential genes, respectively. (a) BPNA SEED b) BPNA ENT c) BPNA FRO d) BPNA HIPP e) BPNA TEM ) Table 2 list of all pathways and their appearance in brain regions. Classification performed based on a function of pathways. Identical pathways were highlighted by two-star. Table 3 -Comparison between selected pathways that are resulted from the enrichment of top 10 genes in degree and their neighbors of GRN networks. Table 4 -Summary of Cross-validation statistics. Numbers of up or down-regulated genes per brain region and percent of their validity in literature were shown.
